A dark blue background featuring a large, light blue Caduceus symbol—a winged staff with two entwined snakes—positioned on the right side.

Cancer 2035: A Roadmap for the Future

23–24 February 2026 | Washington, DC

Co-hosted by the Milken Institute and the Richard Nixon Foundation, Cancer 2035: A Roadmap for the Future brings together leading oncologists, researchers, policymakers, and influential industry experts to examine how today’s scientific and technological capabilities can drive the next era of biomedical progress.

The event coincides with a pivotal milestone: the 55th anniversary of the National Cancer Act, landmark legislation that transformed the nation’s approach to cancer and set in motion decades of scientific and clinical progress.

Join health leaders as they discuss what it would take—in research, technology, policy, financing, and care delivery—to dramatically reduce cancer mortality by 2035.

Watch the Event Discussion

Program

February 23–24, 2026

The program will include fireside chats and panel discussions on:

The Next Decade of Defeating Cancer: Visions for What’s Possible

Prevention, Early Detection, and Interception

Designing the Clinical Trial Infrastructure of the Future

Mobilizing the Full Ecosystem: The Next Generation of Public–Private Partnerships

Accelerating the Future of Oncology

Technology as a Force Multiplier: Delivering Innovation at Scale

Click here for program details.

Speakers

Lucille Accetta
Chief Pharmacy Officer, CVS Health

Noubar Afeyan 
CEO, Flagship Pioneering

Jim Allison
Nobel Laureate, Regental Chair and Professor of Immunology, MD Anderson Cancer Center

Margaret Anderson
Managing Partner, Deloitte

Charles Balch
President, International Society of Oncology Prevention and Treatment

Monica Bertagnolli
17th Director, National Institutes of Health

Luciana Borio
Venture Partner, ARCH Venture Partners

Shelley Moore Capito
US Senator, West Virginia
Chair, US Senate Appropriations Subcommittee on Department of Labor, HHS, and Education, and Related Agencies

Gina Carithers
President & CEO, Prostate Cancer Foundation 

Francis Collins
16th Director, National Institutes of Health

Diana DeGette
US Representative, Colorado
Ranking Member, US House Energy and Commerce Subcommittee on Health 

William Doyle
Executive Chairman, Novocure

Helmy Eltoukhy
Chairman and Co-CEO, Guardant Health

Melanie Eisenhower
Board Member, Richard Nixon Foundation

Andrew von Eschenbach
21st Commissioner, FDA; 12th Director, National Cancer Institute

David Fredrickson
Executive Vice President, AstraZeneca

Jackie Gerhart
Chief Medical Officer, Epic

Mark Goldsmith
CEO, Revolution Medicines

Marjorie Green
SVP, Head of Oncology, Merck

Leroy Hood
Co-founder, Institute for Systems Biology

Cliff Hudis
CEO, American Society of Clinical Oncology

Carl June
Professor of Immunotherapy, University of Pennsylvania Perelman School of Medicine

Edward Kim
Vice Physician-in-Chief, City of Hope National Medical Center

Karen Knudsen
CEO, Parker Institute for Cancer Immunotherapy

Pablo Legorreta
Founder, CEO, & Chairman, Royalty Pharma 

Anthony Letai
Director, National Cancer Institute

Harlan Levine
President, Health Innovation and Policy, City of Hope

William Li
CEO, Angiogenesis Foundation

Joe Lopez
Acting President & CEO, Richard Nixon Foundation

Sharmila Makhija
Founding Dean & CEO, Alice L. Walton School of Medicine

Marlene Malek
Vice Chair and Co-Founder, Friends of Cancer Research

Mark McClellan
Director, Duke-Margolis Institute for Health Policy

Kimberly Myers
Principal, Deloitte

Prineha Narang
Professor in Physical Sciences and Electrical and Computer Engineering, UCLA

William Nelson
Director, Sidney Kimmel Comprehensive Cancer Center

Robert O'Brien
Chairman, Richard Nixon Foundation

Anaeze Offodile
Chief Strategy Officer, Memorial Sloan Kettering

Mehmet Oz
Administrator, Centers for Medicare & Medicaid Services 

Richard Pazdur
Founding Director, Oncology Center of Excellence, FDA

Padmanee Sharma
Professor of Genitourinary Medical Oncology
Professor of Immunology, MD Anderson Cancer Center

Greg Simon
President, Simonovation; Founding Executive Director, FasterCures

Patrick Soon-Shiong
Founder, ImmunityBio

Jean-Charles Soria
Senior Vice President, Global Development Oncology, Amgen

Grant Verstandig
Founder, Chairman, and CEO, Red Cell Partners; Co-Founder and Executive Chairman at Zephyr A

George Yancopoulos
Co-founder, President, and Chief Scientific Officer, Regenero

Elias Zerhouni
15th Director, National Institutes of Health

Event Partner

Sponsors

We thank the following organizations for their support, allowing us to achieve our mission of accelerating progress on the path to a meaningful life.